STSA

Satsuma Pharmaceuticals, Inc. Common Stock
STSA

Overview Fund Activity
Delisted

STSA was delisted on the 7th of June, 2023.

Back to rankings

52 hedge funds and large institutions have $396M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+16
Holders Change %
+44.44%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
21
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$9.71M
2
IC
Ikarian Capital
Texas
+$9.46M
3
GTC
Ghost Tree Capital
New York
+$6.47M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.47M
5
State Street
State Street
Massachusetts
+$1.96M

Top Sellers

1
CC
Caxton Corporation
New Jersey
-$15.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$14.2M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$13.5M
4
CS
Credit Suisse
Switzerland
-$1.17M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$280K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
$19K +$19K +739 New
CS
52
Credit Suisse
Switzerland
– -$1.17M -54,296 Closed
Osaic Holdings
53
Osaic Holdings
Arizona
– -$128K -5,925 Closed
Victory Capital Management
54
Victory Capital Management
Texas
– -$46K -2,162 Closed
1 2
3